NCT04391842View on ClinicalTrials.gov

Sustained Acoustic Medicine (SAM) Combined With a Diclofenac Ultrasound Coupling Patch for Knee Osteoarthritis

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Osteo Arthritis KneeArthritis
Interventions
COMBINATION_PRODUCT

Sustained Acoustic Device with 1% Diclofenac patch

"Patients apply the Sam Ultrasonic Diathermy Device daily for 4 hours of continuous therapeutic ultrasound at 3 megahertz (MHz) frequency and 0.132 Watts/cm2 with 1% diclofenac patch~Other Names:~* ZetrOZ ultrasound device~* wearable ultrasound device~* long duration ultrasound~* LITUS device~* long duration low intensity device"

Trial Locations (1)

13053

Cayuga Medical Center -, Dryden

All Listed Sponsors
lead

ZetrOZ, Inc.

INDUSTRY

NCT04391842 - Sustained Acoustic Medicine (SAM) Combined With a Diclofenac Ultrasound Coupling Patch for Knee Osteoarthritis | Biotech Hunter | Biotech Hunter